Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
HK Stock MarketDetailed Quotes
BAMBOOSHEALTH (02293)
- 0.380
- 0.0000.00%
Trading May 22 09:00 CST
152.93MMarket Cap9.05P/E (TTM)
0.000High0.000Low0Volume0.000Open0.380Prev Close0.00Turnover0.00%Turnover Ratio8.64P/E (Static)402.46MShares0.57552wk High0.60P/B152.93MFloat Cap0.36552wk Low0.02Dividend TTM402.46MShs Float2.160Historical High0.040Dividend LFY0.00%Range %0.010Historical Low--Avg Price4000Lot Size3.95%Div Yield TTM10.53%Div Yield LFY
BAMBOOSHEALTH (02293) Cash Flow
All
YOY
| (Q6)Dec 31, 2025 | (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -42.83%22.43M | ---- | -33.14%39.23M | ---- | -19.00%58.67M | ---- | -1.42%72.44M | ---- | 103.12%73.48M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -20.64%-1.58M | ---- | -68.98%-1.31M | ---- | -1,366.04%-777K | ---- | 40.45%-53K | ---- | 91.51%-89K |
| Interest expense - adjustment | ---- | 17.36%3.29M | ---- | 44.05%2.81M | ---- | 151.35%1.95M | ---- | 279.90%775K | ---- | -37.42%204K |
| Dividend (income)- adjustment | ---- | 69.45%-172K | ---- | 24.43%-563K | ---- | 42.11%-745K | ---- | -4.21%-1.29M | ---- | ---1.24M |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -87.03%89K |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -88.36%340K | ---- | --2.92M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.43M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -73.62%129K | ---- | --489K |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --211K | ---- | ---- |
| Revaluation surplus: | ---- | -110.57%-240K | ---- | 1,983.49%2.27M | ---- | -93.06%109K | ---- | 179.06%1.57M | ---- | -47.08%-1.99M |
| -Other fair value changes | ---- | -110.57%-240K | ---- | 1,983.49%2.27M | ---- | -93.06%109K | ---- | 179.06%1.57M | ---- | -47.08%-1.99M |
| Depreciation and amortization: | ---- | -8.66%9.26M | ---- | 1.43%10.14M | ---- | 29.95%9.99M | ---- | 76.31%7.69M | ---- | -24.86%4.36M |
| Special items | ---- | 11.27%632K | ---- | 3,055.56%568K | ---- | -96.18%18K | ---- | -82.19%471K | ---- | 4.22%2.64M |
| Operating profit before the change of operating capital | ---- | -36.73%33.62M | ---- | -23.24%53.13M | ---- | -15.53%69.22M | ---- | 1.94%81.94M | ---- | 85.28%80.39M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -77.70%169K | ---- | -38.52%758K | ---- | 140.71%1.23M | ---- | -1,946.95%-3.03M | ---- | 864.71%164K |
| Accounts receivable (increase)decrease | ---- | 130.72%16.96M | ---- | 577.27%7.35M | ---- | -107.42%-1.54M | ---- | 150.29%20.76M | ---- | -340.15%-41.27M |
| Accounts payable increase (decrease) | ---- | 60.85%-6.35M | ---- | -151.51%-16.21M | ---- | -133.63%-6.44M | ---- | 27.52%19.16M | ---- | 516.75%15.03M |
| prepayments (increase)decrease | ---- | -16.49%4M | ---- | 1,790.91%4.78M | ---- | -81.77%253K | ---- | -46.94%1.39M | ---- | 197.47%2.62M |
| Special items for working capital changes | ---- | 80.00%-41K | ---- | 89.14%-205K | ---- | -2,804.62%-1.89M | ---- | -144.83%-65K | ---- | -77.45%145K |
| Cash from business operations | ---- | -2.54%48.35M | ---- | -18.44%49.61M | ---- | -49.37%60.83M | ---- | 110.55%120.16M | ---- | 3.87%57.07M |
| Other taxs | ---- | 18.10%-9.99M | ---- | 35.45%-12.2M | ---- | -367.05%-18.9M | ---- | 45.52%-4.05M | ---- | 26.81%-7.43M |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 37.42%-204K |
| Special items of business | -60.70%6.92M | ---- | 3,614.97%17.61M | ---- | -108.46%-501K | ---- | -91.43%5.92M | ---- | 310.34%69.1M | ---- |
| Net cash from operations | -60.70%6.92M | 2.53%38.36M | 3,614.97%17.61M | -10.78%37.42M | -108.46%-501K | -63.88%41.94M | -91.43%5.92M | 134.86%116.11M | 310.34%69.1M | 11.17%49.44M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 20.64%1.58M | ---- | 7.62%1.31M | ---- | -56.18%1.22M | ---- | -0.22%2.78M | ---- | 166.22%2.79M |
| Dividend received - investment | ---- | -69.45%172K | ---- | -24.43%563K | ---- | -42.11%745K | ---- | 4.21%1.29M | ---- | --1.24M |
| Decrease in deposits (increase) | ---- | ---9.42M | ---- | ---- | ---- | ---- | ---- | 200.00%5.2M | ---- | ---5.2M |
| Purchase of fixed assets | ---- | -8.97%-1.81M | ---- | -536.78%-1.66M | ---- | 98.34%-261K | ---- | -71,454.55%-15.74M | ---- | 99.16%-22K |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---170.63M | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --303K |
| Recovery of cash from investments | ---- | 1,779.52%46.61M | ---- | -71.76%2.48M | ---- | -86.59%8.78M | ---- | 535.82%65.48M | ---- | -6.07%10.3M |
| Cash on investment | ---- | -788.71%-86.96M | ---- | -174.17%-9.79M | ---- | ---3.57M | ---- | ---- | ---- | -112.25%-80.79M |
| Other items in the investment business | 50.73%-2.72M | ---- | -200.38%-5.51M | ---- | -158.66%-1.84M | ---- | 102.46%3.13M | ---- | -98.58%-127.12M | ---- |
| Net cash from investment operations | 50.73%-2.72M | -602.59%-49.82M | -200.38%-5.51M | -202.52%-7.09M | -158.66%-1.84M | 106.20%6.92M | 102.46%3.13M | -56.39%-111.63M | -98.58%-127.12M | -148.96%-71.38M |
| Net cash before financing | -65.24%4.21M | -137.79%-11.46M | 617.89%12.1M | -37.93%30.32M | -125.81%-2.34M | 990.23%48.85M | 115.60%9.05M | 120.42%4.48M | -22.99%-58.03M | -238.85%-21.94M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --93M | ---- | ---- |
| Refund | ---- | 15.59%-2.03M | ---- | 11.18%-2.41M | ---- | 89.06%-2.71M | ---- | ---24.77M | ---- | ---- |
| Interest paid - financing | ---- | -20.26%-3.28M | ---- | -50.14%-2.73M | ---- | 41.15%-1.82M | ---- | -1.38%-3.08M | ---- | ---3.04M |
| Dividends paid - financing | ---- | 42.71%-20.12M | ---- | -0.35%-35.12M | ---- | 12.50%-35M | ---- | -100.00%-40M | ---- | 33.33%-20M |
| Other items of the financing business | 34.54%-8.73M | ---- | 17.77%-13.33M | ---- | 27.24%-16.21M | ---- | -141.61%-22.28M | ---- | 550.46%53.54M | -166.67%-2K |
| Net cash from financing operations | 34.54%-8.73M | 38.52%-26.09M | 17.77%-13.33M | -1.54%-42.44M | 27.24%-16.21M | -266.19%-41.8M | -141.61%-22.28M | 209.14%25.15M | 550.46%53.54M | 29.89%-23.04M |
| Effect of rate | 486.96%178K | -750.00%-51K | -2,400.00%-46K | 89.09%-6K | 110.00%2K | -266.67%-55K | 25.93%-20K | -850.00%-15K | -157.45%-27K | 166.67%2K |
| Net Cash | -266.67%-4.52M | -209.95%-37.55M | 93.35%-1.23M | -271.71%-12.12M | -40.21%-18.55M | -76.19%7.06M | -195.09%-13.23M | 165.87%29.63M | 92.41%-4.48M | -163.57%-44.98M |
| Begining period cash | -46.34%43.54M | -13.00%81.15M | -13.00%81.15M | 8.12%93.27M | 8.12%93.27M | 52.28%86.27M | 52.28%86.27M | -44.26%56.65M | -44.26%56.65M | -14.38%101.63M |
| Cash at the end | -50.92%39.2M | -46.34%43.54M | 6.89%79.87M | -13.00%81.15M | 2.33%74.72M | 8.12%93.27M | 40.04%73.02M | 52.28%86.27M | 22.35%52.14M | -44.26%56.65M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | --22.9M | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | PwC | -- | PwC | -- | PwC |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"